Position 5-7: Finalization

Ear

Select the specific approach and device combination to identify the exact billable procedure code.

Approach 3

Percutaneous

Device 0

3E0B304 Introduction Ear to Liquid Brachytherapy Radioisotope with Antineoplastic, Percutaneous Approach
3E0B305 Introduction Ear to Other Antineoplastic with Antineoplastic, Percutaneous Approach
3E0B30M Introduction Ear to Monoclonal Antibody with Antineoplastic, Percutaneous Approach

Device 2

3E0B328 Introduction Ear to Oxazolidinones with Anti-infective, Percutaneous Approach
3E0B329 Introduction Ear to Other Anti-infective with Anti-infective, Percutaneous Approach

Device 3

3E0B33Z Introduction Ear to No Qualifier with Anti-inflammatory, Percutaneous Approach

Device B

3E0B3BZ Introduction Ear to No Qualifier with Anesthetic Agent, Percutaneous Approach

Device G

3E0B3GC Introduction Ear to Other Substance with Other Therapeutic Substance, Percutaneous Approach

Device H

3E0B3HZ Introduction Ear to No Qualifier with Radioactive Substance, Percutaneous Approach

Device K

3E0B3KZ Introduction Ear to No Qualifier with Other Diagnostic Substance, Percutaneous Approach

Device N

3E0B3NZ Introduction Ear to No Qualifier with Analgesics, Hypnotics, Sedatives, Percutaneous Approach

Device T

3E0B3TZ Introduction Ear to No Qualifier with Destructive Agent, Percutaneous Approach
Approach 7

Via Natural or Artificial Opening

Device 0

3E0B704 Introduction Ear to Liquid Brachytherapy Radioisotope with Antineoplastic, Via Natural or Artificial Opening Approach
3E0B705 Introduction Ear to Other Antineoplastic with Antineoplastic, Via Natural or Artificial Opening Approach
3E0B70M Introduction Ear to Monoclonal Antibody with Antineoplastic, Via Natural or Artificial Opening Approach

Device 2

3E0B728 Introduction Ear to Oxazolidinones with Anti-infective, Via Natural or Artificial Opening Approach
3E0B729 Introduction Ear to Other Anti-infective with Anti-infective, Via Natural or Artificial Opening Approach

Device 3

3E0B73Z Introduction Ear to No Qualifier with Anti-inflammatory, Via Natural or Artificial Opening Approach

Device B

3E0B7BZ Introduction Ear to No Qualifier with Anesthetic Agent, Via Natural or Artificial Opening Approach

Device G

3E0B7GC Introduction Ear to Other Substance with Other Therapeutic Substance, Via Natural or Artificial Opening Approach

Device H

3E0B7HZ Introduction Ear to No Qualifier with Radioactive Substance, Via Natural or Artificial Opening Approach

Device K

3E0B7KZ Introduction Ear to No Qualifier with Other Diagnostic Substance, Via Natural or Artificial Opening Approach

Device N

3E0B7NZ Introduction Ear to No Qualifier with Analgesics, Hypnotics, Sedatives, Via Natural or Artificial Opening Approach

Device T

3E0B7TZ Introduction Ear to No Qualifier with Destructive Agent, Via Natural or Artificial Opening Approach
Approach X

External

Device 0

3E0BX04 Introduction Ear to Liquid Brachytherapy Radioisotope with Antineoplastic, External Approach
3E0BX05 Introduction Ear to Other Antineoplastic with Antineoplastic, External Approach
3E0BX0M Introduction Ear to Monoclonal Antibody with Antineoplastic, External Approach

Device 2

3E0BX28 Introduction Ear to Oxazolidinones with Anti-infective, External Approach
3E0BX29 Introduction Ear to Other Anti-infective with Anti-infective, External Approach

Device 3

3E0BX3Z Introduction Ear to No Qualifier with Anti-inflammatory, External Approach

Device B

3E0BXBZ Introduction Ear to No Qualifier with Anesthetic Agent, External Approach

Device G

3E0BXGC Introduction Ear to Other Substance with Other Therapeutic Substance, External Approach

Device H

3E0BXHZ Introduction Ear to No Qualifier with Radioactive Substance, External Approach

Device K

3E0BXKZ Introduction Ear to No Qualifier with Other Diagnostic Substance, External Approach

Device N

3E0BXNZ Introduction Ear to No Qualifier with Analgesics, Hypnotics, Sedatives, External Approach

Device T

3E0BXTZ Introduction Ear to No Qualifier with Destructive Agent, External Approach